{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:08:57Z","timestamp":1786115337664,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cefaly Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-05028-8","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:43:57Z","timestamp":1780451037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Migraine phases and treatment response: a post hoc analysis of participants with migraine with aura from the TEAM study"],"prefix":"10.1186","volume":"26","author":[{"given":"Michael A. L.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Panza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena E.","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"10258","key":"5028_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"1","key":"5028_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z. Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137.","journal-title":"J Headache Pain"},{"issue":"10419","key":"5028_CR3","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/S0140-6736(23)01683-5","volume":"402","author":"DW Dodick","year":"2023","unstructured":"Dodick DW, Goadsby PJ, Schwedt TJ, et al. Ubrogepant for the treatment of migraine attacks during the prodrome. Lancet. 2023;402(10419):2307\u201316.","journal-title":"Lancet"},{"issue":"3","key":"5028_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11916-022-01022-0","volume":"26","author":"DE Kuruvilla","year":"2022","unstructured":"Kuruvilla DE, Bilchik T. Preventing the progression of episodic migraine to chronic migraine with acute treatment optimization. Curr Pain Headache Rep. 2022;26(3):253\u20138.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"5028_CR5","first-page":"1","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"issue":"9","key":"5028_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629\u2013808.","journal-title":"Cephalalgia"},{"issue":"3","key":"5028_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/ije\/24.3.612","volume":"24","author":"MB Russell","year":"1995","unstructured":"Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995;24(3):612\u20138.","journal-title":"Int J Epidemiol"},{"issue":"Pt 1","key":"5028_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/brain\/117.1.199","volume":"117","author":"M Lauritzen","year":"1994","unstructured":"Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory. Brain. 1994;117(Pt 1):199\u2013210.","journal-title":"Brain"},{"issue":"3","key":"5028_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1523\/JNEUROSCI.13-03-01167.1993","volume":"13","author":"MA Moskowitz","year":"1993","unstructured":"Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci. 1993;13(3):1167\u201377.","journal-title":"J Neurosci"},{"issue":"5","key":"5028_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/ana.22329","volume":"69","author":"X Zhang","year":"2011","unstructured":"Zhang X, Levy D, Kainz V, et al. Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol. 2011;69(5):855\u201365.","journal-title":"Ann Neurol"},{"issue":"26","key":"5028_CR11","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1523\/JNEUROSCI.0511-10.2010","volume":"30","author":"X Zhang","year":"2010","unstructured":"Zhang X, Levy D, Noseda R, et al. Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci. 2010;30(26):8807\u201314.","journal-title":"J Neurosci"},{"issue":"2","key":"5028_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nm0202-136","volume":"8","author":"H Bolay","year":"2002","unstructured":"Bolay H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002;8(2):136\u201342.","journal-title":"Nat Med"},{"issue":"6","key":"5028_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1152\/jn.1947.10.6.409","volume":"10","author":"AAP Leao","year":"1947","unstructured":"Leao AAP. Further observations on the spreading depression of activity in the cerebral cortex. J Neurophysiol. 1947;10(6):409\u201314.","journal-title":"J Neurophysiol"},{"issue":"9","key":"5028_CR14","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1212\/WNL.44.9.1587","volume":"44","author":"D Bates","year":"1994","unstructured":"Bates D, Ashford E, Dawson R, et al. Subcutaneous sumatriptan during the migraine aura. Neurology. 1994;44(9):1587\u201392.","journal-title":"Neurology"},{"issue":"10","key":"5028_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1468-1331.2004.00914.x","volume":"11","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener HC, Schoenen J, Hettiarachchi J. No effect of eletriptan administration during the aura phase of migraine. Eur J Neurol. 2004;11(10):671\u20137.","journal-title":"Eur J Neurol"},{"issue":"7","key":"5028_CR16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/j.1526-4610.2009.01429.x","volume":"49","author":"SK Aurora","year":"2009","unstructured":"Aurora SK, Barrodale PM, McDonald SA, Jakubowski M, Burstein R. Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine. Headache. 2009;49(7):1001\u20134.","journal-title":"Headache"},{"issue":"1","key":"5028_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10194-019-1046-4","volume":"20","author":"JM Hansen","year":"2019","unstructured":"Hansen JM, Charles A. Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs. J Headache Pain. 2019;20(1):96.","journal-title":"J Headache Pain"},{"issue":"Suppl 2","key":"5028_CR18","first-page":"28","volume":"36","author":"A Dowson","year":"1996","unstructured":"Dowson A. Can oral 311C90, a novel 5-HT1D agonist, prevent migraine headache when taken during an aura? Eur Neurol. 1996;36(Suppl 2):28\u201331.","journal-title":"Eur Neurol"},{"key":"5028_CR19","unstructured":"Health & Human Services: Food and Drug Administration. FDA 510K clearance transcutaneous electrical nerve stimulator to treat headache CEFALY de novo summary (K122566).U.S. Food and Drug Administration. De Novo Classification Request for CEFALY: Transcutaneous Electrical Nerve Stimulator to Treat Headache (DEN120019). Silver Spring (MD): Food and Drug Administration; 2014. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/DEN120019.pdf.\u00a0 Accessed 2 Jun 2026."},{"issue":"1","key":"5028_CR20","first-page":"22","volume":"10","author":"MAJ Johnson","year":"2022","unstructured":"Johnson MAJ, Kuruvilla D. External trigeminal nerve stimulation as a non-pharmacological option for the prevention and acute treatment of migraine. Rev Touch Neurol. 2022;10(1):22.","journal-title":"Rev Touch Neurol"},{"issue":"1","key":"5028_CR21","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41598-022-09071-6","volume":"12","author":"DE Kuruvilla","year":"2022","unstructured":"Kuruvilla DE, Mann JI, Tepper SJ, et al. Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM). Sci Rep. 2022;12(1):5110.","journal-title":"Sci Rep"},{"issue":"1\u20134","key":"5028_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF01541794","volume":"119","author":"G Salar","year":"1992","unstructured":"Salar G, Ori C, Iob I, et al. Cerebral blood flow changes induced by electrical stimulation of the Gasserian ganglion after experimentally induced subarachnoid haemorrhage in pigs. Acta Neurochir (Wien). 1992;119(1\u20134):115\u201320.","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"5028_CR23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3171\/jns.2002.97.5.1179","volume":"97","author":"B Atalay","year":"2002","unstructured":"Atalay B, Bolay H, Dalkara T, et al. Transcorneal stimulation of trigeminal nerve afferents to increase cerebral blood flow in rats with cerebral vasospasm. J Neurosurg. 2002;97(5):1179\u201383.","journal-title":"J Neurosurg"},{"issue":"4","key":"5028_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1227\/NEU.0000000000001854","volume":"90","author":"KA Shah","year":"2022","unstructured":"Shah KA, White TG, Powell K, et al. Trigeminal nerve stimulation improves cerebral macrocirculation and microcirculation after subarachnoid hemorrhage. Neurosurgery. 2022;90(4):485\u201394.","journal-title":"Neurosurgery"},{"issue":"3","key":"5028_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/head.14488","volume":"63","author":"IE Verhagen","year":"2023","unstructured":"Verhagen IE, van der Arend BWH, van Casteren DS, et al. Sex differences in migraine attack characteristics: a longitudinal E-diary study. Headache. 2023;63(3):333\u201341.","journal-title":"Headache"},{"key":"5028_CR26","doi-asserted-by":"publisher","unstructured":"Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB. Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the AMPP Study. Headache. 2020.Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB. Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2020;60(10):2340\u201356. https:\/\/doi.org\/10.1111\/head.13966.","DOI":"10.1111\/head.13966"},{"issue":"20","key":"5028_CR27","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1001\/jama.284.20.2599","volume":"284","author":"RB Lipton","year":"2000","unstructured":"Lipton RB, Stewart WF, Stone AM, L\u00e1inez MJA, Sawyer JPC. Stratified care vs step care strategies for migraine: The Disability in Strategies of Care (DISC) Study:A randomized trial. JAMA. 2000;284(20):2599\u2013605. https:\/\/doi.org\/10.1001\/jama.284.20.2599.","journal-title":"JAMA"},{"issue":"Pt 8","key":"5028_CR28","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1093\/brain\/aws175","volume":"135","author":"N Maleki","year":"2012","unstructured":"Maleki N, Linnman C, Brawn J, et al. Her versus his migraine: multiple sex differences in brain function and structure. Brain. 2012;135(Pt 8):2546\u201359.","journal-title":"Brain"},{"issue":"2","key":"5028_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553\u2013622.","journal-title":"Physiol Rev"},{"issue":"11\u201312","key":"5028_CR30","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/03331024211010413","volume":"41","author":"C Tassorelli","year":"2021","unstructured":"Tassorelli C, Diener HC, Silberstein SD, et al. Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine. Cephalalgia. 2021;41(11\u201312):1135\u201351.","journal-title":"Cephalalgia"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05028-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05028-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05028-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T01:49:28Z","timestamp":1785980968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05028-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5028"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05028-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The TEAM study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. The protocol and informed consent were approved by the ADVARRA Institutional Review Board (central IRB; protocol #51401), which is independent and not affiliated with any of the authors\u2019 institutions or study sites. All participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are consultants for Cefaly Technology.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"498"}}